PharmX Technologies(AU:PHX)
A$0.07+0.00 (+1.47%)
AU:PHX
PharmX Technologies financials statements
A$0.07
At close:+0.00 (+1.47%)
Want to see AU:PHX full AI Analyst Report?
PharmX Technologies (PHX) Ratios
2 Followers
PharmX Technologies Ratios
AU:PHX's free cash flow for Q3 2025 was AU$296.00K. For the 2025 fiscal year, AU:PHX's free cash flow was increased by AU$0.00 and operating cash flow was AU$296.00K. See a summary of the company’s cash flow.
| Ratios | Jun 25 | Jun 24 | Jun 23 | Jun 22 | Jun 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.33 | 3.33 | 1.37 | 1.84 | 1.68 |
| Quick Ratio | 2.33 | 3.33 | 1.37 | 1.84 | 1.67 |
| Cash Ratio | 0.80 | 2.41 | 1.10 | 1.04 | 1.13 |
| Solvency Ratio | -0.07 | 0.35 | -0.04 | -0.00 | 0.32 |
| Operating Cash Flow Ratio | 0.26 | -4.70 | 0.00 | 0.00 | 0.00 |
| Short-Term Operating Cash Flow Coverage | 3.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | AU$ 3.51M | AU$ 2.86M | AU$ 2.48M | AU$ 8.28M | AU$ 1.02M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.05 | 0.01 | 0.00 | 0.01 |
| Debt-to-Equity Ratio | 0.02 | 0.06 | 0.02 | 0.00 | 0.01 |
| Debt-to-Capital Ratio | 0.02 | 0.05 | 0.01 | 0.00 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.17 | 1.18 | 1.87 | 1.64 | 1.33 |
| Debt Service Coverage Ratio | -1.08 | 33.71 | 31.19 | 3.06 | 31.89 |
| Interest Coverage Ratio | -47.50 | -45.90 | -31.70 | -14.33 | 4.79 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 3.82 | -2.36 | -8.91 | -38.83 | -2.14 |
| Profitability Margins | |||||
| Gross Profit Margin | -0.92% | 81.43% | 80.98% | 79.89% | 88.27% |
| EBIT Margin | -27.44% | 1.50% | 3.76% | -11.05% | 3.10% |
| EBITDA Margin | -6.98% | 18.96% | 22.31% | 5.47% | 21.34% |
| Operating Profit Margin | -27.44% | -19.44% | -21.01% | -12.86% | 2.85% |
| Pretax Profit Margin | -26.44% | 1.08% | 3.10% | -11.95% | 2.50% |
| Net Profit Margin | -23.97% | -3.61% | -27.27% | -17.46% | 2.11% |
| Continuous Operations Profit Margin | -23.97% | -3.61% | 1.46% | -14.67% | 0.15% |
| Net Income Per EBT | 90.67% | -334.18% | -880.10% | 146.18% | 84.56% |
| EBT Per EBIT | 96.36% | -5.55% | -14.75% | 92.89% | 87.65% |
| Return on Assets (ROA) | -6.70% | -1.40% | -5.92% | -2.88% | 0.82% |
| Return on Equity (ROE) | -7.84% | -1.66% | -11.08% | -4.73% | 1.09% |
| Return on Capital Employed (ROCE) | -8.69% | -8.32% | -7.61% | -3.19% | 1.33% |
| Return on Invested Capital (ROIC) | -7.79% | 27.25% | -3.58% | -3.19% | 0.08% |
| Return on Tangible Assets | -11.77% | -3.75% | -10.45% | -4.54% | 2.51% |
| Earnings Yield | -2.27% | -0.38% | -2.57% | -1.53% | 0.37% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.72 | 6.55 | 2.86 | 6.36 | 10.99 |
| Payables Turnover | 4.27 | 2.64 | 2.17 | 1.81 | 1.66 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 33.31 |
| Fixed Asset Turnover | 13.98 | 9.08 | 26.70 | 128.04 | 19.77 |
| Asset Turnover | 0.28 | 0.39 | 0.22 | 0.16 | 0.39 |
| Working Capital Turnover Ratio | 1.83 | 1.73 | 0.88 | 0.87 | 0.00 |
| Cash Conversion Cycle | 48.61 | -82.62 | -40.52 | -144.73 | -175.24 |
| Days of Sales Outstanding | 134.08 | 55.70 | 127.78 | 57.38 | 33.22 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 10.96 |
| Days of Payables Outstanding | 85.47 | 138.32 | 168.30 | 202.11 | 219.42 |
| Operating Cycle | 134.08 | 55.70 | 127.78 | 57.38 | 44.18 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Per Share | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| Dividend Paid and CapEx Coverage Ratio | 41.25 | -290.46 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | 41.25 | -290.46 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | 1.53 | -9.10 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.11 | -1.11 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | 1.00% | -11.86% | 0.00% | 0.00% | 0.00% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -44.83 | -287.50 | -38.89 | -65.34 | 272.33 |
| Price-to-Sales (P/S) Ratio | 10.58 | 9.40 | 10.60 | 11.41 | 5.76 |
| Price-to-Book (P/B) Ratio | 3.46 | 4.32 | 4.31 | 3.09 | 2.96 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 100.11 | -8.43 | 0.00 | 0.00 | 0.00 |
| Price-to-Operating Cash Flow Ratio | 97.69 | -8.46 | 0.00 | 0.00 | 0.00 |
| Price-to-Earnings Growth (PEG) Ratio | -0.07 | 3.32 | -0.58 | 0.12 | 0.00 |
| Enterprise Value Multiple | -147.67 | 47.23 | 38.63 | 169.91 | 24.84 |
| Enterprise Value | 78.56M | 65.55M | 55.89M | 55.90M | 63.19M |
| EV to EBITDA | -147.67 | 47.23 | 38.63 | 169.91 | 24.84 |
| EV to Sales | 10.31 | 8.95 | 8.62 | 9.29 | 5.30 |
| EV to Free Cash Flow | 97.59 | -8.03 | 0.00 | 0.00 | 0.00 |
| EV to Operating Cash Flow | 95.22 | -8.06 | 0.00 | 0.00 | 0.00 |
| Tangible Book Value Per Share | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 |
| Shareholders’ Equity Per Share | 0.04 | 0.03 | 0.03 | 0.04 | 0.04 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.09 | 4.34 | 0.53 | -0.23 | 0.94 |
| Revenue Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
| Net Income Per Share | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 |
| Tax Burden | 0.91 | -3.34 | -8.80 | 1.46 | 0.85 |
| Interest Burden | 0.96 | 0.72 | 0.82 | 1.08 | 0.81 |
| Research & Development to Revenue | 0.13 | -0.04 | -0.02 | -0.01 | -0.04 |
| SG&A to Revenue | 0.95 | 0.74 | 0.39 | 0.42 | 0.69 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.45 | 30.81 | 0.00 | 0.00 | 0.00 |
Currency in AUD
